Lagicad 10000IU Injection is a pharmaceutical preparation containing ASPARAGINASE as its active ingredient, classified under the Anti Cancer general category and the Oncology speciality domain. Asparaginase is an enzyme that depletes circulating asparagine, an amino acid essential for the survival of certain leukemic cells, thereby starving malignant lymphoblasts of a nutrient they cannot synthesise on their own. Manufactured by CADILA PHARMACEUTICALS LTD. As with any prescription medicine, dosage and treatment duration must be individualised by the treating specialist based on the patient's diagnosis, disease stage, organ function, and concurrent medications.

Uses of Lagicad 10000IU Injection
Used in the treatment of acute lymphoblastic leukemia (ALL), usually as part of a combination chemotherapy protocol.

Lagicad 10000IU Injection containing ASPARAGINASE works as described: Asparaginase is an enzyme that depletes circulating asparagine, an amino acid essential for the survival of certain leukemic cells, thereby starving malignant lymphoblasts of a nutrient they cannot synthesise on their own. Therapeutically, it is classified under the Anti Cancer category and Oncology speciality domain. Regular monitoring by the treating specialist is recommended to assess treatment response and manage side effects.

• Always inform your doctor about every medicine, supplement, or herbal product you are currently taking before starting Lagicad 10000IU Injection. Concurrent use with vincristine or corticosteroids requires careful sequencing as advised by the oncologist; asparaginase can also alter clotting factor levels, so monitoring with other drugs affecting coagulation is advised.

Lagicad 10000IU Injection is available under medical guidance and should be used strictly as advised by a licensed specialist. Storage: Store in a refrigerator (2°C to 8°C). Do not freeze. Protect from light. Disposal: Do not flush unused product or dispose of it in household waste; return unused or expired product to a licensed pharmacy. Manufactured by CADILA PHARMACEUTICALS LTD and complies with applicable regulatory standards.